Project Sessions

11:00

Coordination

G. Schmidt1, P. Hermann2, B. Kong3, S. Roth4, M. Hollenbach5, M. Breunig6

1Göttingen, Göttingen, Deutschland, 2Ulm, Deutschland, 3Munich, Deutschland, 4Heidelberg, Deutschland, 5Leipzig, Deutschland, 6Ulm, Deutschland

11:01

Introduction

E. Hessmann1, D. Saur2

1Göttingen, Deutschland, 2Munich, Deutschland

11:10

Collaborative Research – the Göttingen experience.

E. Hessmann

Göttingen, Deutschland

11:20

Collaborative Research – the Munich experience (SFB).

D. Saur

Munich, Deutschland

11:30

The PRECODE project – the Erlangen experience.

C. Pilarsky

Deutschland

11:40

Round Table Discussion.

12:20

Wrap-up, Preparation of 1-2 slide presentation with key points

11:00

Coordination

J. D´Haese1, A. Neesse2, E. Demir3, L. Perkhofer4, L. Bolm5, T. Kraus6, C. Teske7

1Munich, Deutschland, 2Göttingen, Deutschland, 3Munich, Deutschland, 4Ulm, Deutschland, 5Lübeck, Deutschland, 6Munich, Deutschland, 7Dresden, Deutschland

11:01

Introduction and Aims

J. Siveke1, T. Seufferlein2

1Essen, Deutschland, 2Ulm, Deutschland

11:10

Centralized/Regionalized Pancreatic Cancer Care – Perspectives from Sweden.

E. Rangelova

Stockholm, Schweden

11:35

Priority Setting Pancreatic Cancer. Results and plans for further steps.

A. Mihaljevic

Heidelberg, Deutschland

11:45

Study presentation: NEOPANORGA.

T. Seufferlein

Ulm, Deutschland

11:55

Study presentation: METAPANC.

J. Siveke

Essen, Deutschland

12:05

Tailored perioperative antibiotic prophylaxis for pancreatoduodenectomy – time for a multicenter RCT?

T. Welsch

Dresden, Deutschland

12:15

SMARD – Symptoms after SMA resection/reconstruction.

F. Rückert

Mannheim, Deutschland

12:25

Round table discussion. Definition of milestones to be completed until September 2020 (DGVS/DGAV conference).

11:00

Introduction and Aim

A. König1, J. Schrader2

1Deutschland, 2Hamburg, Deutschland

11:10

Current studies in Germany – Do we need better/other approaches?

A. Rinke

Marburg, Deutschland

11:20

NET Register – new data, ongoing projects

11:35

In vitro Models for neuroendocrine tumors – overview.

J. Schrader

Hamburg, Deutschland

11:45

From preclinical to clinical, relevant new targets.

P. Grabowski

Berlin, Deutschland

12:00

Novel approaches surgery for neuroendocrine tumor patients.

S. Schimmack

Heidelberg, Deutschland

12:15

Round table discussion. Definition of milestones.

13:00

Introduction.

E. Costello1, J. Mayerle2

1Liverpool, Deutschland, 2Munich, Deutschland

13:10

The Liverpool experience: screening in people with newly diagnosed diabetes mellitus.

E. Costello

Liverpool, Deutschland

13:25

The Istanbul experience.

M. Erkan

Instanbul, Deutschland

13:35

Approach to biobanking in large screening approaches.

B. Greenhalf

Liverpool, Deutschland

13:45

Round Table discussion. A Roadmap for NDDM PDAC Screening in Germany (including potential funding and national collaboration)

13:00

Coordination

G. Beyer1, L. Schulte2, K. Honselmann3, U. Klaiber4

1Munich, Deutschland, 2Ulm, Deutschland, 3Lübeck, Deutschland, 4Heidelberg, Deutschland

13:01

Introduction

T. Hackert

Heidelberg, Deutschland

13:05

Molecular Diagnostics in precursor lesions and in pancreatic cancer.

A. Kleger

Ulm, Deutschland

13:25

Preliminary title: German Pancreas Cyst Registry.

K. Honselmann1, M. Damm2

1Kiel, Deutschland, 2Halle (Saale), Deutschland

13:35

Preliminary Title: Machine Learning to Predict Survival in Pancreatic Cancer.

R. Braren

Munich, Deutschland

13:45

Round Table discussion. Definition of milestones.